Loading organizations...
CXO platform offering biosafety testing and process validation.
Hengyu Biotechnology has raised $27.8M across 1 funding round.
Hengyu Biotechnology has raised $27.8M in total across 1 funding round.
Hengyu Biotechnology has raised $27.8M in total across 1 funding round.
Hengyu Biotechnology's investors include CMB International, 鲁赛, UMC Capital.
Hengyu Biotechnology has raised $27.8M across 1 funding round. Most recently, it raised $27.8M Series B in March 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 11, 2024 | $27.8M Series B | CMB International | 鲁赛, UMC Capital |